AI Article Synopsis
- The study investigated the prevalence of Hepatitis B surface antigen (HBs Ag) in HIV-positive patients at Maradi CHR from 2006 to 2018.
- A total of 2,770 HIV-infected individuals were analyzed, revealing a 5.74% coinfection rate with HBs Ag, notably higher in men (52.20%).
- The findings highlight the importance of routine screening for Hepatitis B in HIV patients to improve their management and health outcomes.
Article Abstract
Objective: The present study aimed to determine the seroprevalence of HBs Ag in HIV-infected patients followed at the Maradi CHR.
Methods: This is a retrospective study based on the records of the infectious diseases department of the CHR of Maradi. Included were all HIV-positive adults seen in consultation who received HBs Ag research between 2006 and 2018. The data was collected from patients' medical records.
Results: In total, 2770 patients included in our study. The average age of the cohort was 38 years old. Of these patients, 159 had HBs Ag or a prevalence of 5.74% (95% CI: 4.93 - 6.67). HIV-HBV coinfections were higher in men (52.20%). HIV1 subtype was involved in 96.86% of cases. Two patients co-infected with HIV-HBV had HIV1 and HIV2 dual profile. Which represents 1.26% (95% CI: 0.15 - 4.47).
Conclusion: This study confirms the high prevalence rate of HBV coinfection in HIV-infected patients. It is therefore necessary to screen all HIV-infected patients for better management.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!